LuciRit 50 MG (Ritlecitinib)

Description

Ritlectinib

Each LuciRit capsule contains Ritlecitinib tosylate 80.13 mg equivalent to Ritlecitinib … 50 mg

INDICATION

LuciRit is a kinase inhibitor indicated for the treatment of severe alopecia areata in adults and adolescents 12 years and older.

DOSAGE AND USE

The recommended dosage of LuciRit is 50 mg orally once daily with or without food. If treatment interruption is indicated, a temporary treatment interruption for less than 6 weeks is not expected to result in significant loss of regrown scalp hair. Capsul e should be swallowed whole & not chewed or crushed

STORAGE

In a dry place and store at 20°C to 25°C.

MANUFACTURED AND MARKETED BY

LUCIUS PHARMACEUTICALS(LAO) CO., LTD No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos

WARNING

Keep medicine out of reach of Children. Do not administered LuciRit in Pregnancy and Lactation patient treatment.